Bevacizumab Plus Atezolizumab in Pretreated Progressive and Metastatic NSCLC. Zhao B, Li H, Ma W. J Thorac Oncol 2022;17:e71-e72.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao B, Li H, Ma W. Bevacizumab Plus Atezolizumab in Pretreated Progressive and Metastatic NSCLC. J Thorac Oncol 2022;17:e71-e72.
PMID: 36031288